ANROVSVTGN• 28 Days (Normalized)
ANRO vs VTGN (Alto Neuroscience Inc. vs Vistagen Therapeutics Inc.)
Showing Closing Date Range from Aug 31 to Sep 28, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ANRO Performance $27.5
-22.27%
Alto Neuroscience Inc.
Normalized Baseline0.00%
VTGN Performance $0.37
+42.31%
Vistagen Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin VTGN LEADS
-64.58 pts
VTGN outperforming by 64.58 percentage points
ANROVTGN
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ANRO VTGN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(17 dates)
| Date | ANRO Price | ANRO Gain (%) | VTGN Price | VTGN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $27.50 | -22.27% | $0.37 | +42.31% | -64.58% |
| Sep 22, 2026 | $30.78 | -13.00% | $0.25 | -3.85% | -9.15% |
| Sep 21, 2026 | $30.63 | -13.43% | $0.23 | -11.54% | -1.89% |
| Sep 18, 2026 | $30.27 | -14.44% | $0.24 | -7.69% | -6.75% |
| Sep 17, 2026 | $30.98 | -12.44% | $0.23 | -11.54% | -0.90% |
| Sep 16, 2026 | $30.00 | -15.21% | $0.23 | -11.54% | -3.67% |
| Sep 15, 2026 | $30.25 | -14.50% | $0.24 | -7.69% | -6.81% |
| Sep 14, 2026 | $31.68 | -10.46% | $0.24 | -6.46% | -4.00% |
| Sep 11, 2026 | $32.00 | -9.55% | $0.24 | -7.69% | -1.86% |
| Sep 10, 2026 | $31.68 | -10.46% | $0.24 | -7.69% | -2.77% |
| Sep 09, 2026 | $34.07 | -3.70% | $0.24 | -7.69% | +3.99% |
| Sep 08, 2026 | $35.81 | +1.22% | $0.24 | -7.69% | +8.91% |
| Sep 04, 2026 | $35.55 | +0.48% | $0.24 | -7.69% | +8.17% |
| Sep 03, 2026 | $36.40 | +2.88% | $0.25 | -3.85% | +6.73% |
| Sep 02, 2026 | $36.64 | +3.56% | $0.25 | -3.85% | +7.41% |
Page 1 of 2